The head of the global organization responsible for vaccinating children in the world’s poorest countries is headed to ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a wide economic moat. Growth of existing products and new product launches should help offset ...

The global influenza vaccine market size was US$ 5,417.24 million in 2021. The global influenza vaccine market is forecast to grow to US$ 11,212.32 million by 2030 by growing at a compound annual ...

The global animal vaccines market size was US$ 8.5 billion in 2021. The global animal vaccines market is forecast to grow to US$ 13.3 billion by 2030 by growing at a compound annual growth rate (CAGR) ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

"I think we were contrarians,” Sanofi's chief digital officer Emmanuel Frenehard told Fortune. “I think the contrarians are ...

The new head of the Food and Drug Administration previously made headlines for his comments during the COVID-19 pandemic.

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

The Trump administration plans to end U.S. funding for Gavi, a global program that purchases shots to help vaccinate children ...

Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential ...

As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.